Related references
Note: Only part of the references are listed.Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice
Xu-Liang Luo et al.
SCIENTIFIC REPORTS (2020)
Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo
Wen Bu et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2020)
Breast cancer animal models and applications
Li Zeng et al.
ZOOLOGICAL RESEARCH (2020)
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis
Huda I. Atiya et al.
ANTICANCER RESEARCH (2019)
Patient-Derived Xenograft Models of Breast Cancer and Their Application
Takahiko Murayama et al.
CELLS (2019)
Comparative Profiling of Metastatic 4T1-vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer
Jonas Steenbrugge et al.
FRONTIERS IN IMMUNOLOGY (2019)
MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis
Arnab Ghosh et al.
PLOS ONE (2018)
Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer
Jonas Steenbrugge et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
The prognostic effects of somatic mutations in ER-positive breast cancer
Obi L. Griffith et al.
NATURE COMMUNICATIONS (2018)
NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer
Patrick S. Dischinger et al.
NPJ BREAST CANCER (2018)
Reinforcement strategy for lateral rafting plate fixation in posterolateral column fractures of the tibial plateau: The magic screw technique
Hui Sun et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2017)
Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2-positive breast cancer
Vanesa G. Martinez et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research
Tsutomu Kawaguchi et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2017)
Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma
S. Ando et al.
ONCOGENE (2017)
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
W. Song et al.
ONCOGENE (2017)
A murine preclinical syngeneic transplantation model for breast cancer precision medicine
Lorenzo Federico et al.
SCIENCE ADVANCES (2017)
In vivo models in breast cancer research: progress, challenges and future directions
Ingunn Holen et al.
DISEASE MODELS & MECHANISMS (2017)
Mammary Ductal Environment Is Necessary for Faithful Maintenance of Estrogen Signaling in ER+ Breast Cancer
Svasti Haricharan et al.
CANCER CELL (2016)
A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response
George Sflomos et al.
CANCER CELL (2016)
Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype
Kimberly R. Holloway et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
Amy V. Paschall et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis
Rajneesh Pathania et al.
NATURE COMMUNICATIONS (2015)
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Peter Eirew et al.
NATURE (2015)
Patient-derived xenograft models of breast cancer and their predictive power
James R. Whittle et al.
BREAST CANCER RESEARCH (2015)
Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis
S. R. Chan et al.
CELL DEATH AND DIFFERENTIATION (2014)
The anticancer effect of PQ1 in the MMTV-PyVT mouse model
Stephanie N. Shishido et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer
S. Haricharan et al.
ONCOGENE (2014)
Triple-Negative Breast Cancer and the Need for New Therapeutic Targets
Olav Engebraaten et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer
Andrea Lunardi et al.
NATURE GENETICS (2013)
Reduced Androgen Receptor Expression Accelerates the Onset of ERBB2 Induced Breast Tumors in Female Mice
Myles C. Hodgson et al.
PLOS ONE (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy
Svasti Haricharan et al.
ELIFE (2013)
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
Patrick J. Roberts et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Molecular profiling of patient-derived breast cancer xenografts
Fabien Reyal et al.
BREAST CANCER RESEARCH (2012)
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Szeman Ruby Chan et al.
BREAST CANCER RESEARCH (2012)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
A Compendium of the Mouse Mammary Tumor Biologist: From the Initial Observations in the House Mouse to the Development of Genetically Engineered Mice
Robert D. Cardiff et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Choosing the right cell line for breast cancer research
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2011)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis
J. Zhang et al.
ONCOGENE (2010)
Estrogen-Induced Aurora Kinase-A (AURKA) Gene Expression is Activated by GATA-3 in Estrogen Receptor-Positive Breast Cancer Cells
Shoulei Jiang et al.
Hormones & Cancer (2010)
Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model
Rachel L. Ruhlen et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis
Babette Schade et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The RCAS-TVA System for Introduction of Oncogenes into Selected Somatic Mammary Epithelial Cells in Vivo
Jay P. Reddy et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
Fariba Behbod et al.
BREAST CANCER RESEARCH (2009)
Imagable 4T1 model for the study of late stage breast cancer
Kai Tao et al.
BMC CANCER (2008)
The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression
Reena Shakya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Estrogen-induced breast cancer: Alterations in breast morphology and oxidative stress as a function of estrogen exposure
Sarah M. Mense et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors
Stefan K. Siwko et al.
NEOPLASIA (2008)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
Serial transplantation of NMU-induced rat mammary tumors: A model of human breast cancer progression
Maren M. Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
Xiaoling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A mouse model of basal-like breast carcinoma with metaplastic elements
A. McCarthy et al.
JOURNAL OF PATHOLOGY (2007)
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models
Zhijun Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice
AGSH van Rossum et al.
BMC CANCER (2006)
Mouse models of breast cancer metastasis
Anna Fantozzi et al.
BREAST CANCER RESEARCH (2006)
Collaboration of Brca1 and Chk2 in tumorigenesis
JP McPherson et al.
GENES & DEVELOPMENT (2004)
VEGF-DT385 toxin conjugate inhibits mammary adenocarcinoma development in a transgenic mouse model of spontaneous tumorigenesis
R Wild et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Models of breast cancer: is merging human and animal models the future?
JB Kim et al.
BREAST CANCER RESEARCH (2004)
Oestrogen exposure and breast cancer risk
RC Travis et al.
BREAST CANCER RESEARCH (2003)
Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer
Z Weaver et al.
ONCOGENE (2002)
Cre/LoxP-mediated inactivation of the murine Pten tumor suppressor gene
R Lesche et al.
GENESIS (2002)
Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models
RL Sutherland et al.
BREAST CANCER RESEARCH (2002)
Tumor formation in Brca1 conditional mutant mice
CX Deng
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2002)
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers et al.
NATURE GENETICS (2001)
β-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland
JS Michaelson et al.
ONCOGENE (2001)
Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice
T Ludwig et al.
ONCOGENE (2001)
Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
XL Xu et al.
NATURE GENETICS (2001)
Rat strain-specific actions of 17β-estradiol in the mammary gland:: Correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers
DME Harvell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer
Y Li et al.
ONCOGENE (2000)
Share Paper
